Product
MF59
1 clinical trial
1 indication
Indication
Avian InfluenzaClinical trial
A Phase I Cohort-Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants: Assessment of Immunological Responses and Lymphocyte InterplayStatus: Completed, Estimated PCD: 2018-12-19